Emadine Ophthalmic Drops, Solution 0.05pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Emadine: Ophthalmic drops, solution (0.05%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Emadine 0.05% Ophth Soln

What is this Medicine?

EMEDASTINE (em e DAS teen) is an antihistamine for use in the eye. It is used to prevent itching of the eye caused by allergies.

CVS Pharmacy Patient Statistics for Emadine: Ophthalmic drops, solution(0.05%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Emadine 0.05% Ophthalmic Solution

NDC: 000650325
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Conjunctivitis, Ocular Pruritus

Storage Information
Do not use more than 30 days after opening
Store below 77 degrees F
Emadine 0.05% Ophthalmic Solution

Reported Side Effects for Emadine 0.05% Ophthalmic Solution

Eye Inflammatoin Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Sinus Infection Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Dry Eyes Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Blurred Vision Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Corneal Deposits Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Foreign Body Sensation Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Engorgement With Blood Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Secretion Of Tears Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Rhinitis Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
11.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Emadine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5